ESCRS Homepage

March 2003
IN THIS ISSUE

New ESCRS trial in bid to cut endophthalmitis rate to 0.01%


Lasik corrects refractive errors after PK in selected patients

Africa-Luz mobilises to provide eye care in regions riven by poverty

Multifocal IOL
choice hinges on patterns of daily routine

Anti-histamine drug mitigates risk of developing DLK after Lasik, says study

Untreated eyelid inflammatory disorders pose risk for postoperative complications

Thermotopography shows ‘enormous promise’
for diagnosis and treatment of eye diseases

Lasik offers ‘very effective treatment’ for
refractive errors after PK, says US specialist

Good results with PRK and Lasek rival Lasik for top spot in refractive excimer laser surgery

Orbital lymphomas respond well to local, systemic therapies, says study

Laser technologies still beam but economy and consumer demand will determine future of refractive surgery

Legally blind cardiologist finds new beat in low vision rehabilitation

‘Pivotal’ anti-TGF antibody therapy reduces
filtering bleb wound formation, says report

Neuroprotective agents stem optic nerve damage
by ‘offering a solution’ to open-angle glaucoma

Echothiophate iodide shortage leaves US specialists struggling to find alternative for acute cases

Postoperative complications of PK will have serious consequences unless tackled 'aggressively’

Private refractive clinics claim young specialists as public waiting lists grow in Canadian eye surgery

German doctors’ helpers oil the cogs of the private ophthalmic practice

Study of 900 ICLs reveals good safety and long-term refractive results, says Spanish specialist

New toric IOL corrects high corneal astigmatism after cataract surgery, Austrian study reveals

IVF children run increased risk of developing
retinoblastoma, claim Dutch researchers

Suture-free DLEK preserves corneal surface topography and ensures faster wound healing

The day I said goodbye to cataracts and hello to the world without glasses

Retina specialists and trauma ophthalmologists
prepare to trade notes at joint Hungarian conference

Night blindness casts bogeyman into the shadows

Erbium laser phaco requires longer time but less energy for moderately hard cataracts

FEATURES
From The Editor
Reflections on Refractive Surgery
In Your Good Books
Bio-ophthalmology
In The Driving Seat
Prime Site
The Collector's Eye
Regulatory Matters



New toric IOL corrects high corneal astigmatism after cataract surgery, Austrian study reveals

By Stefanie Petrou-Binder MD
in Berlin

Irene Dejaco-Ruhswurm MD
RESULTS from recent Austrian study show that a new foldable, toric IOL with z-haptics can correct high corneal astigmatism and produce a good visual outcome, Irene Dejaco-Ruhswurm MD told the annual meeting of the German Society of Ophthalmology.

She and her team at the University Clinic for Ophthalmology and Optometry, Vienna, Austria implanted individually crafted toric silicone IOLs (MicroSil 6116 TU, Schmidt) in 14 eyes of nine patients. Four of the patients had previously undergone keratoplasty.

“The implantation of toric IOLs to reduce pre-existing corneal astigmatism may improve visual acuity after cataract surgery. But the correction of high corneal astigmatism, for example after keratoplasty, was limited until now,” she said.
The MicroSil 6116 lens is a three piece foldable silicon IOL with z-haptics. The diagonal length is 11.6 mm and the optical diameter 6.0 mm.

The cataract surgery was standard in all cases. Eleven of the patients had a sclerocorneal incision, and the remaining three had a clear corneal incision. The surgeon implanted the toric IOL through the 3.2 mm incision with a pair of tweezers recommended by the manufacturer, or alternately with a micro-injector.
While the insertion of the lens with tweezers required more experienced surgical skill, IOL injection using a micro-injector was more easily reproducible.

The investigators evaluated visual acuity with and without the best spherical and the best corrected visual acuity at one week, and one, three, six, and 12 months postoperatively. They also measured the refraction, corneal astigmatism and postoperative rotation of the IOL. All patients had a minimal follow-up of six months.
Dr Dejaco-Ruhswurm calculated the cylindrical power of the lens individually for each patient, depending on the degree of keratometric astigmatism. Schmidt, which produces the lens, manufactures lenses with cylindrical power of up to 12 D.

The mean preoperative keratometric astigmatism was 5.28 D (± 3.53 D) and the mean preoperative refractive astigmatism 3.73 D (± 1.52 D). Four of the patients underwent PK. The mean cylindrical power of the implanted IOLs was 5.50 D (± 2.74 D.)
The refractive astigmatism was reduced to +0.68 D (± 0.75 D) following surgery. The mean amount of postoperative keratometric astigmatism was +4.62 D (± 3.32 D).
Visual acuity without correction was 0.55. With spherical correction, it registered 0.7 and BCVA acuity was 0.8. The researchers observed no significant IOL rotation in nine patients followed for six months or more.

At the XX ESCRS Congress in Nice in September last year, Dr Sven Kulus and colleagues from the Klinik Dardenne in Germany reported that the MS 6116 performed well in six eyes with high astigmatism following keratoplasty. Post-PK keratoplasty astigmatism was reduced from a mean of 7.5 D to 2.4 D following IOL implantation.


Irene Dejaco-Ruhswurm MD
Vienna University Eye Clinic, Austria
Email: irene.ruhswurm@univie.ac.at

 

Top